Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, Agate L, Cappagli V, Miccoli P, Berti P, Faviana P, Ugolini C, Basolo F, Vitti P, Pinchera A. The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience [...]
Read more »Recent Posts
SCREENING AND TREATMENT OF THYROID ABNORMALITIES IN EARLY PREGNANCY
Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, Chiusano E, John R, Guaraldo V, George LM, Perona M,
Read more »3% OF MNG PATIENTS WITH RAI TREATMENT NEED THYROIDECTOMY
Need for thyroidectomy in patients treated with radioactive iodide for benign thyroid disease.Villadsen MJ, Sørensen CH, Godballe C, Nygaard B. Dan Med Bull. 2011 Dec;58(12):A4343. ABSTRACT-Nodular toxic and non-toxic goitres are seen in approximately 15% of Danish women, and the pros and cons of thyroidectomy versus radioiodine (RI) therapy are often discussed. The purpose of [...]
Read more »RAI VS SURGERY FOR THYROID REMNANT ABLATION
Outpatient Thyroid Remnant Ablation Using Repeated Low 131-Iodine Activities (740 MBq/20 mCi x 2) in Patients with Low-Risk Differentiated Thyroid Cancer. Clerc J, Bienvenu-Perrard M, Pichard de Malleray C, Dagousset F, Delbot T, Dreyfuss M, Groussin L, Marlowe RJ, Leger FA, Chevalier A. J Clin Endocrinol Metab. 2012 Jan 11. ABSTRACT- In low-risk differentiated thyroid [...]
Read more »MORE ON LOW DOSE THYROID AB LATION
Outpatient Thyroid Remnant Ablation Using Repeated Low 131-Iodine Activities (740 MBq/20 mCi x 2) in Patients with Low-Risk Differentiated Thyroid Cancer. Clerc J, Bienvenu-Perrard M, Pichard de Malleray C, Dagousset F, Delbot T, Dreyfuss M, Groussin L, Marlowe RJ, Leger FA, Chevalier A. J Clin Endocrinol Metab. 2012 Jan 11. ABSTRACT- In low-risk differentiated thyroid [...]
Read more »